Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C
R. J. de Knegt, G. Bezemer, A. R. Van Gool, J. P. H. Drenth, B. E. Hansen, H. A. Droogleever Fortuyn, C. J. Weegink, M. W. Hengeveld, H. L. A. JanssenVolume:
34
Year:
2011
Language:
english
Pages:
12
DOI:
10.1111/j.1365-2036.2011.04867.x
File:
PDF, 250 KB
english, 2011